Green Cross Lab Cell Corporation (144510) — Cash Flow-to-Debt Ratio
Green Cross Lab Cell Corporation (144510) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of ₩6.67 Billion could theoretically repay 0% of its total liabilities (₩134.23 Billion) in one year. See 144510 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Green Cross Lab Cell Corporation Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Green Cross Lab Cell Corporation across 10 annual periods. Also explore 144510 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Green Cross Lab Cell Corporation (2015–2024)
Year-by-year debt coverage analysis for Green Cross Lab Cell Corporation. For market capitalisation and broader financial context, see market cap of Green Cross Lab Cell Corporation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | ₩11.34 Billion | ₩120.56 Billion | ▲ +217.0% |
| 2023 | 0.03x | ₩3.67 Billion | ₩123.69 Billion | ▼ -93.8% |
| 2022 | 0.48x | ₩66.42 Billion | ₩138.07 Billion | ▲ +170.8% |
| 2021 | 0.18x | ₩23.91 Billion | ₩134.57 Billion | ▼ -43.0% |
| 2020 | 0.31x | ₩9.09 Billion | ₩29.19 Billion | ▲ +3254.2% |
| 2019 | 0.01x | ₩223.04 Million | ₩24.02 Billion | ▼ -81.9% |
| 2018 | 0.05x | ₩490.92 Million | ₩9.55 Billion | ▼ -87.4% |
| 2017 | 0.41x | ₩2.86 Billion | ₩7.03 Billion | ▲ +980.1% |
| 2016 | -0.05x | ₩-296.65 Million | ₩6.42 Billion | ▼ -124.6% |
| 2015 | 0.19x | ₩1.49 Billion | ₩7.90 Billion | — |